6550--intent to sole source to the binding site SPA and reagents - albany

The Department of Veterans Affairs, Albany VA Medical Center, Department of Pathology & Laboratory Services, 113 Holland Ave. Albany, NY 12208 intends to solicit and negotiate with only one source under the authority of FAR 6.302-1(a)(2), “Only one responsible source and no other supplies or services will satisfy agency requirements.”  The NAICS code is 324513 with a small business size standard of 1,250 employees.  The VA intends to solicit and negotiate with The Binding Site, 6730 Mesa Ridge Rd. San Diego, CA 92121 for a serum protein analyzer’s Free Kappa and Free Lambda Light Chain reagents as well as applicable ancillary items.

Special Notice of Intent to Sole Source to The Binding Site for the following items:

Item #

Description

0001

KFree Kit for Optillite 100 tests/kit

0002

LFree kit for Optillite 100 tests/kit

0003

KFree Urine Kit for Optilite. 100 TESTS/KIT

0004

LFree Urine Kit for Optilite. 100 TESTS/KIT.

0005

Optilite Diluent 1.

0006

Sample Cups 0.5ml.

0007

Sample Cups 2ml

0008

Optilite Cuvettes TENCELL.

0009

Washing Solution 20ml.

0010

Washing Solution 100ml.

0011

Tubing Maintenance Solution 20ml.

0012

Special Wash.

The serum protein analyzer’s Free Kappa and Free Lambda Light Chain reagents as well as applicable ancillary items are to be used with Optilite Protein Analyzer.  This protein analyzer system and associated reagents and consumables is for the performance of Serum and Urine Free Kappa and Free Lambda Light Chain Testing, to include reagent kits, calibrators, quality controls, diluents, wash solutions, sample cups, cuvettes, and any associated analyzer maintenance items as well as analyzer service and support. The analyzer and testing methodology must perform both Serum and Urine Free Light Chain Assays, be capable of detecting antigen excess, be capable of automatically diluting specimens to end results, and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical Laboratory Standards Institute (CLSI) The reagents must be FDA approved for the diagnosis and monitoring of plasma cell dyscrasias. The contractor will perform set up and validation of the analyzer and assist with establishing an interface connection with the VA laboratory information system (VistA). In addition, the contractor will provide hands on instruction to train two key operators in the use, maintenance and routine troubleshooting of the proposed analyzer.

Other persons may identify their interest by responding to this requirement by Friday, June 12, 2020 at 10 am EST.  Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis.  All information shall be furnished at no cost or obligation to the Government.  A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government.  No solicitation is available at this time.   All inquiries must be submitted by email to Idalia Algarin at Idalia.algarin@va.gov.

Enter “RFQ 36C24220Q0670_1 Spa & Reagents – Albany” in the email subject line.